Author

Leana Laraque

Observed name: L. Laraque

Institution: Memorial Sloan Kettering Cancer Center

Observed institution: Memorial Sloan Kettering Cancer Center

OpenAlex ID: A5053646102

Brentuximab Vedotin Combined With Chemotherapy in Patients With Newly Diagnosed Early-Stage, Unfavorable-Risk Hodgkin Lymphoma

2021 · Anita Kumar, Carla Casulo, et al. · Journal of Clinical Oncology · 58

Interim Analysis from a Prospective Multicenter Study of Next-Generation Sequencing Minimal Residual Disease Assessment and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

2020 · Anita Kumar, Jason Westin, et al. · Blood · 11

Frontline Sequential Immunochemotherapy Plus Lenalidomide for Mantle Cell Lymphoma Incorporating MRD Evaluation: Phase II, Investigator-Initiated, Single-Center Study

2020 · Zachary D. Epstein-Peterson, Connie Lee Batlevi, et al. · Blood · 7

Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation

2023 · Zachary D. Epstein-Peterson, Esther Drill, et al. · Haematologica · 5

A Prospective Multicenter Study of Minimal Residual Disease Assessment Using a Next-Generation Immunosequencing Assay and CT Monitoring for Surveillance after Frontline Treatment in Diffuse Large B-Cell Lymphoma

2021 · Anita Kumar, Jason R. Westin, et al. · Blood · 4

Erratum to: Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation

2024 · Zachary D. Epstein-Peterson, Esther Drill, et al. · Haematologica · 2

Phase I Study of Bendamustine, Rituximab, Ibrutinib, and Venetoclax in Relapsed, Refractory Mantle Cell Lymphoma

2021 · A. Kumar, C. Batlevi, et al. · Hematological Oncology · 2

Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design

2022 · Anita Kumar, Carla Casulo, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 1

Initial Results of a Phase II Study of Sequential Chemotherapy and Lenalidomide Followed By Rituximab and Lenalidomide Maintenance for Untreated Mantle Cell Lymphoma

2018 · Anita Kumar, Andrew D. Zelenetz, et al. · Blood · 1

Similarities between HeLa cells and the Brooklyn bridge.

2016 · Leana Laraque · Wheaton College Digital Repository (Wheaton College (MA))

Works count: 10

Citation count: 91

H-index: 4

I10-index: 2